M. Birdsall et al., INHIBIN-A AND ACTIVIN-A IN THE FIRST-TRIMESTER OF HUMAN-PREGNANCY, The Journal of clinical endocrinology and metabolism, 82(5), 1997, pp. 1557-1560
Recent studies show that high concentrations of inhibin A and activin
A are present in the maternal serum throughout human pregnancy. The ai
m of this study was to determine whether the corpus luteum produces si
gnificant quantities of inhibin A and activin A during the first trime
ster of pregnancy. This prospective study examined two groups of women
who had blood samples taken from 5-12 weeks gestation. One group cons
isted of 14 women with donor egg pregnancies (8 singletons and 6 multi
ples) who did not have corpora lutea, and the other group consisted 5
women with spontaneous pregnancies who had corpora lutea. Inhibin A an
d activin A were measured at weekly intervals using specific enzyme im
munoassays. All pregnancies progressed to term, with healthy babies be
ing delivered. Maternal serum concentrations of inhibin A significantl
y increased throughout the study period in the donor egg pregnancies (
P < 0.001) and the control pregnancies (P < 0.001). Circulating concen
trations of activin A also increased significantly in both the spontan
eous and donor egg pregnancies (P < 0.001) during the study period. Ho
wever, the concentrations of inhibin A and activin A in the first trim
ester of human pregnancy were not significantly different in the women
with or without corpora lutea, suggesting a fetoplacental origin. mul
tiple donor egg pregnancies were found to have higher concentrations o
f inhibin A (P < 0.001) and activin A (P < 0.05) compared with singlet
on donor egg pregnancies, which also supports a placental source.